Szostak M Anne - May 6, 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak
Stock symbol
IDXX
Transactions as of
May 6, 2024
Transactions value $
$0
Form type
4
Date filed
5/8/2024, 07:02 PM
Previous filing
May 19, 2023
Next filing
Sep 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +257 $0.00 257 May 6, 2024 Direct
transaction IDXX Common Stock Gift $0 -257 -100% $0.00* 0 May 8, 2024 Direct
transaction IDXX Common Stock Gift $0 +257 +4.08% $0.00 6.56K May 8, 2024 Trust of M. Anne Szostak F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +609 $0.00 609 May 6, 2024 Common Stock 609 $476.87 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +262 $0.00 262 May 6, 2024 Common Stock 262 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -257 -100% $0.00* 0 May 6, 2024 Common Stock 257 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,604 shares of IDEXX Laboratories, Inc. common stock contributed by the reporting person to the Trust of M. Anne Szostak (as defined in note (2) below).
F2 The reporting person is the settlor of the Trust of M. Anne Szostak ('Trust') and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.
F4 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.
F5 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier.